Bristol Myers Squibb Revenue 2006-2021 | BMY

Bristol Myers Squibb annual/quarterly revenue history and growth rate from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Bristol Myers Squibb revenue for the quarter ending June 30, 2021 was $11.703B, a 15.54% increase year-over-year.
  • Bristol Myers Squibb revenue for the twelve months ending June 30, 2021 was $44.384B, a 27.31% increase year-over-year.
  • Bristol Myers Squibb annual revenue for 2020 was $42.518B, a 62.62% increase from 2019.
  • Bristol Myers Squibb annual revenue for 2019 was $26.145B, a 15.89% increase from 2018.
  • Bristol Myers Squibb annual revenue for 2018 was $22.561B, a 8.59% increase from 2017.
Bristol Myers Squibb Annual Revenue
(Millions of US $)
2020 $42,518
2019 $26,145
2018 $22,561
2017 $20,776
2016 $19,427
2015 $16,560
2014 $15,879
2013 $16,385
2012 $17,621
2011 $21,244
2010 $19,484
2009 $18,808
2008 $17,715
2007 $15,617
2006 $16,208
2005 $18,605
Bristol Myers Squibb Quarterly Revenue
(Millions of US $)
2021-06-30 $11,703
2021-03-31 $11,073
2020-12-31 $11,068
2020-09-30 $10,540
2020-06-30 $10,129
2020-03-31 $10,781
2019-12-31 $7,945
2019-09-30 $6,007
2019-06-30 $6,273
2019-03-31 $5,920
2018-12-31 $5,973
2018-09-30 $5,691
2018-06-30 $5,704
2018-03-31 $5,193
2017-12-31 $5,449
2017-09-30 $5,254
2017-06-30 $5,144
2017-03-31 $4,929
2016-12-31 $5,243
2016-09-30 $4,922
2016-06-30 $4,871
2016-03-31 $4,391
2015-12-31 $4,287
2015-09-30 $4,069
2015-06-30 $4,163
2015-03-31 $4,041
2014-12-31 $4,258
2014-09-30 $3,921
2014-06-30 $3,889
2014-03-31 $3,811
2013-12-31 $4,441
2013-09-30 $4,065
2013-06-30 $4,048
2013-03-31 $3,831
2012-12-31 $4,191
2012-09-30 $3,736
2012-06-30 $4,443
2012-03-31 $5,251
2011-12-31 $5,454
2011-09-30 $5,345
2011-06-30 $5,434
2011-03-31 $5,011
2010-12-31 $5,111
2010-09-30 $4,798
2010-06-30 $4,768
2010-03-31 $4,807
2009-12-31 $5,033
2009-09-30 $4,788
2009-06-30 $4,665
2009-03-31 $4,322
2008-12-31 $2,367
2008-09-30 $5,254
2008-06-30 $5,203
2008-03-31 $4,891
2007-12-31 $2,228
2007-09-30 $4,601
2007-06-30 $4,471
2007-03-31 $4,317
2006-12-31 $2,507
2006-09-30 $4,154
2006-06-30 $4,871
2006-03-31 $4,676
2005-12-31 $4,417
2005-09-30 $4,767
2005-06-30 $4,889
2005-03-31 $4,532
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $129.683B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00